The Chairman of the Board of Directors, Dr. Charles Githinji, led members of the Kenya BioVax Institute Limited Board on an inspection visit to the Embakasi manufacturing site to assess the ongoing enabling works and overall project progress. Accompanied by the management and technical teams, the Board received detailed briefings on infrastructure development, regulatory readiness, and operational planning milestones.
The visit reaffirmed the Board’s commitment to ensuring that the facility meets international standards and remains aligned with Kenya’s goal of achieving local vaccine production capacity. Dr. Githinji commended the teams for their dedication and urged continued collaboration to accelerate completion and operational readiness of the Embakasi facility — a cornerstone in advancing the nation’s health security agenda.